1 / 6

U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators

U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators.

kiana
Download Presentation

U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators "A number of large clinical trials have recently demonstrated the benefits associated with improving the lipid profile. Because most physicians base prescription decisions on the results of large clinical trials, doctors who are aware of statins are gaining confidence in their use." Pharmaceuticals Analyst Team Frost & Sullivan

  2. Key Features • Frost & Sullivan provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications • in the lipid regulatorsmarket • Market sizing and competitive analysis • Market forecasts and opportunity analysis • Quarterly assessments • End user analysis within each report

  3. What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans

  4. Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit new market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate time scales for strategy implementation • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of companies • Determine which participants will outperform the competition • Assess attractiveness of investing in the market

  5. Key Market Participants Abbott Laboratories Alpharma, Inc./Purepac Pharmaceutical Co. Apotex Corp. Astra Zeneca Pharmaceuticals LP Avant Immunotherapeutics, Inc. Aventis Pharmaceuticals, Inc. Barr Laboratories Bayer Corp. Bristol Myers Squibb Co. CV Therapeutics, Inc. Digital Gene Technologies, Inc. Eli Lilly and Co. Esperion Therapeutics, Inc. Ethypharm SA Geltex Pharmaceuticals, Inc. Genpharm, Inc. GlaxoSmithkline Impax Labs Incyte Genomics, Inc. KOS Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Mylan Pharmaceuticals Novartis Pharmaceuticals Corp. Par Pharmaceuticals, Inc.

  6. For More Information • Call toll free 877 GO FROST (877.463.7876) • Fax toll free 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com

More Related